This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
View All Zacks #1 Ranked Stocks
Zacks News
Albemarle (ALB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Albemarle (ALB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Allegheny Technologies (ATI) Q3 Earnings: A Beat in Store?
by Zacks Equity Research
Allegheny's (ATI) FRP unit is likely to benefit from operational improvements and strong end-market demand.
Will Strong Demand Aid Cleveland-Cliffs' (CLF) Q3 Earnings?
by Zacks Equity Research
Cleveland-Cliffs' (CLF) Q3 results to benefit from strong demand for pellets.
Is a Beat in the Cards for Celanese (CE) in Q3 Earnings?
by Zacks Equity Research
Celanese's (CE) strategic measures including cost savings through productivity actions and efficiency enhancement are expected to drive third-quarter earnings.
Can Albemarle (ALB) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Albemarle (ALB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Higher Costs Dent PPG Industries' (PPG) Q3 Earnings?
by Anindya Barman
PPG Industries (PPG) faces cost pressure associated with raw materials and logistics that is likely to hurt its margins in Q3.
Cal-Maine Foods to Acquire Assets of Featherland Egg Farms
by Zacks Equity Research
Cal-Maine Foods (CALM) inks deal to acquire the egg production, processing, sales and distribution business of Featherland Egg Farms.
5 Chemical Stocks That Are Poised for Solid Upside in Q4
by Anindya Barman
As the chemical industry's upturn is likely to continue in Q4, it would be prudent to zero in on these chemical stocks that have compelling prospects.
5 Reasons to Add Eastman Chemical (EMN) to Your Portfolio
by Anindya Barman
Based on its compelling prospects, we believe Eastman Chemical (EMN) has plenty of upside potential.
Why Should You Add Celanese (CE) to Your Portfolio Now?
by Anindya Barman
Strong fundamentals and compelling growth prospects make Celanese (CE) an attractive choice for investment.